Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution

被引:216
作者
Williams, Gavin J. [1 ]
Zhang, Changsheng [1 ]
Thorson, Jon S. [1 ]
机构
[1] Univ Wisconsin, Sch Pharm, Pharmaceut Sci Div, Lab Biosynthet Chem,Natl Cooperat Drug Discovery, Madison, WI 53705 USA
关键词
D O I
10.1038/nchembio.2007.28
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Natural products, many of which are decorated with essential sugar residues, continue to serve as a key platform for drug development(1). Adding or changing sugars attached to such natural products can improve the parent compound's pharmacological properties, specificity at multiple levels(2), and/ or even the molecular mechanism of action(3). Though some natural-product glycosyltransferases ( GTs) are sufficiently promiscuous for use in altering these glycosylation patterns, the stringent specificity of others remains a limiting factor in natural-product diversification and highlights a need for general GT engineering and evolution platforms. Herein we report the use of a simple high-throughput screen based on a fluorescent surrogate acceptor substrate to expand the promiscuity of a natural-product GT via directed evolution. Cumulatively, this study presents variant GTs for the glycorandomization of a range of therapeutically important acceptors, including aminocoumarins, flavonoids and macrolides, and a potential template for engineering other natural-product GTs.
引用
收藏
页码:657 / 662
页数:6
相关论文
共 32 条
[1]   Colchicine glycorandomization influences cytotoxicity and mechanism of action [J].
Ahmed, Aqeel ;
Peters, Noel R. ;
Fitzgeraldo, Megan K. ;
Watson, James A., Jr. ;
Hoffmann, F. Michael ;
Thorson, Jon S. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (44) :14224-14225
[2]   Substrate specificity of NovM: Implications for novobiocin biosynthesis and glycorandomization [J].
Albermann, C ;
Soriano, A ;
Jiang, JQ ;
Vollmer, H ;
Biggins, JB ;
Barton, WA ;
Lesniak, J ;
Nikolov, DB ;
Thorson, JS .
ORGANIC LETTERS, 2003, 5 (06) :933-936
[4]   The crystal structure of two macrolide glycosyltransferases provides a blueprint for host cell antibiotic immunity [J].
Bolam, David N. ;
Roberts, Shirley ;
Proctor, Mark R. ;
Turkenburg, Johan P. ;
Dodson, Eleanor J. ;
Martinez-Fleites, Carlos ;
Yang, Min ;
Davis, Benjamin G. ;
Davies, Gideon J. ;
Gilbert, Harry J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (13) :5336-5341
[5]  
Bonay P, 1996, J BIOL CHEM, V271, P3719
[6]   Novobiocin: Redesigning a DNA gyrase inhibitor for selective inhibition of Hsp90 [J].
Burlison, Joseph A. ;
Neckers, Len ;
Smith, Andrew B. ;
Maxwell, Anthony ;
Blagg, Brian S. J. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (48) :15529-15536
[7]   Directed evolution of an amine oxidase possessing both broad substrate specificity and high enantioselectivity [J].
Carr, R ;
Alexeeva, M ;
Enright, A ;
Eve, TSC ;
Dawson, MJ ;
Turner, NJ .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (39) :4807-4810
[8]  
Collier AC, 2000, DRUG METAB DISPOS, V28, P1184
[9]   Antibiotic optimization via in vitro glycorandomization [J].
Fu, X ;
Albermann, C ;
Jiang, JQ ;
Liao, JC ;
Zhang, CS ;
Thorson, JS .
NATURE BIOTECHNOLOGY, 2003, 21 (12) :1467-1469
[10]   Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities [J].
Fylaktakidou, KC ;
Hadjipavlou-Litina, DJ ;
Litinas, KE ;
Nicolaides, DN .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (30) :3813-3833